» Articles » PMID: 31100966

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome

Overview
Journal Cells
Publisher MDPI
Date 2019 May 19
PMID 31100966
Citations 209
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cell (MSC)-sourced secretome, defined as the set of MSC-derived bioactive factors (soluble proteins, nucleic acids, lipids and extracellular vesicles), showed therapeutic effects similar to those observed after transplantation of MSCs. MSC-derived secretome may bypass many side effects of MSC-based therapy, including unwanted differentiation of engrafted MSCs. In contrast to MSCs which had to be expanded in culture to reach optimal cell number for transplantation, MSC-sourced secretome is immediately available for treatment of acute conditions, including fulminant hepatitis, cerebral ischemia and myocardial infarction. Additionally, MSC-derived secretome could be massively produced from commercially available cell lines avoiding invasive cell collection procedure. In this review article we emphasized molecular and cellular mechanisms that were responsible for beneficial effects of MSC-derived secretomes in the treatment of degenerative and inflammatory diseases of hepatobiliary, respiratory, musculoskeletal, gastrointestinal, cardiovascular and nervous system. Results obtained in a large number of studies suggested that administration of MSC-derived secretomes represents a new, cell-free therapeutic approach for attenuation of inflammatory and degenerative diseases. Therapeutic effects of MSC-sourced secretomes relied on their capacity to deliver genetic material, growth and immunomodulatory factors to the target cells enabling activation of anti-apoptotic and pro-survival pathways that resulted in tissue repair and regeneration.

Citing Articles

The Hidden Power of the Secretome: Therapeutic Potential on Wound Healing and Cell-Free Regenerative Medicine-A Systematic Review.

Prado-Yupanqui J, Ramirez-Orrego L, Cortez D, Vera-Ponce V, Chenet S, Tejedo J Int J Mol Sci. 2025; 26(5).

PMID: 40076553 PMC: 11899803. DOI: 10.3390/ijms26051926.


Small Extracellular Vesicles Engineered Using Click Chemistry to Express Chimeric Antigen Receptors Show Enhanced Efficacy in Acute Liver Failure.

Lu Y, Chen T, Lin H, Chen Y, Lin Y, Le D J Extracell Vesicles. 2025; 14(2):e70044.

PMID: 39901768 PMC: 11791321. DOI: 10.1002/jev2.70044.


hUC-MSCs Prevent Acute High-Altitude Injury through Apoe/Pdgf-b/p-Erk1/2 Axis in Mice.

Yan S, Bi Y, Liu Q, Song S, Ma L, Ji G Stem Cell Rev Rep. 2025; .

PMID: 39871082 DOI: 10.1007/s12015-024-10840-1.


RNA sequencing reveals key factors modulating TNFα-stimulated odontoblast-like differentiation of dental pulp stem cells.

Irfan M, Kim J, Sreekumar S, Chung S bioRxiv. 2025; .

PMID: 39868289 PMC: 11761799. DOI: 10.1101/2025.01.09.632294.


Protective Effect of Conditioned Medium of Immortalized Human Stem Cells from Exfoliated Deciduous Teeth Against Hair Graying Caused by X-Ray Irradiation via Its Antioxidative Activity.

Katahira Y, Horio E, Yamaguchi N, Sonoda J, Yamagishi M, Miyakawa S Antioxidants (Basel). 2025; 14(1).

PMID: 39857443 PMC: 11760446. DOI: 10.3390/antiox14010109.


References
1.
Kim Y, Kim J, Cho R, Shin D, Lee S, Oh Y . Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway. Exp Mol Med. 2017; 49(1):e284. PMC: 5291836. DOI: 10.1038/emm.2016.127. View

2.
Berglund A, Fortier L, Antczak D, Schnabel L . Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res Ther. 2017; 8(1):288. PMC: 5741939. DOI: 10.1186/s13287-017-0742-8. View

3.
Harrell C, Markovic B, Fellabaum C, Arsenijevic A, Volarevic V . Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother. 2018; 109:2318-2326. DOI: 10.1016/j.biopha.2018.11.099. View

4.
Villatoro A, Alcoholado C, Martin-Astorga M, Fernandez V, Cifuentes M, Becerra J . Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species. Vet Immunol Immunopathol. 2019; 208:6-15. DOI: 10.1016/j.vetimm.2018.12.003. View

5.
Fabre T, Kared H, Friedman S, Shoukry N . IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner. J Immunol. 2014; 193(8):3925-33. PMC: 4185218. DOI: 10.4049/jimmunol.1400861. View